Hi-C for genome-wide detection of enhancer-hijacking rearrangements in routine lymphoid cancer biopsies
Wu, et al.
Cell Genomics. 6(5):101166.
Hi-C FFPE sequencing analysis is highly concordant with FISH and detects additional variants informing diagnosis and treatment in diffuse large B-cell lymphoma
Xu-Monette, et al.
ASH 2025 - Orlando, FL
Application of Hi-c sequencing to detect cryptic and novel structural aberrations in lymphoid neoplasms
Rozenova, et al.
ASH 2025 - Orlando, FL
Cytogenetic Advances in NHL Diagnosis by Leveraging Hi-C Sequencing
Sikkink, et al.
AMP 2025 - Boston, MA
Hi-C FFPE Sequencing for Detection of Fusions and Rearrangements that are Diagnostic, Prognostic, and Therapeutic Biomarkers in Lymphoma
Hastie, et al.
Lymphoma, Leukemia & Myeloma Congress 2025 - New York, New York
Hi-C Technology Reveals Actionable Gene Fusions and Rearrangements in Diffuse Large B-Cell Lymphoma Unidentified by Conventional FISH
Liang, et al.
Genes (Basel). 16(9):1093.
Aventa Lymphoma based on Hi-C FFPE Sequencing is an Alternative to FISH and Detects Additional Variants Informing Diagnosis and Therapy in Lymphomas
Hastie, et al.
16th Annual Meeting of the Cancer Genomics Consortium - Houston, TX
Evaluation of Hi-C Sequencing for Detection of Gene Fusions in Hematologic and Solid Tumor Pediatric Cancer Samples
Schmitt, et al.
Cancers (Basel). 16(17):2936.
Large B-cell lymphoma with mystery rearrangement: Applying Hi-C to the detection of clinically relevant structural abnormalities
Prior, et al.
Br J Haematol. 205(3):1225.